Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

  • Paths of Progress Fall/Winter 2012

    An 'Evolving' Partnership Yields Success

    By Robert Levy

    Kornelia Polyak, MD, PhDKornelia Polyak, MD, PhD 

    Dana-Farber scientist Kornelia Polyak, MD, PhD, remembers reading The Beak of the Finch, a book about two researchers who observed evolution unfold among certain songbirds on the Galapagos Islands, and thinking, "This could be applied to tumors."

    A self-described "fan of evolution," Polyak has made several trips to the Galapagos, a group of islands off the coast of Ecuador famous as the inspiration for Charles Darwin's theory of evolution by natural selection. The visits have not only fed her fascination with the diversity of life but also stimulated her interest in the behavior of cancer cells.

    In the mid-2000s, Polyak met a similarly evolution-minded scientist, Franziska Michor, then a graduate student in Harvard's Evolutionary Biology Department, now the principal investigator at the Physical Science-Oncology Center. Their conversations "evolved" into a full-fledged partnership that has resulted in several research projects in recent years.

    In one study, they explored the order in which genetic alterations occur in certain types of breast cancer, information that may improve doctors' ability to detect the disease in early stages, gauge a patient's degree of risk, and even prevent the disease. In another study, they found that cells within a single breast tumor are far from identical in terms of the genetic mutations they carry, suggesting that such tumors may best be treated with several mutation-targeting drugs.

    "The idea that evolution plays a role in the growth and development of tumors is not new, but our ability to study it at a molecular level is," Polyak says. "The better we understand heterogeneity – the genetic and non-genetic diversity of cells within a tumor – the smarter we can be about selecting the best treatment."

    Paths of Progress Fall/Winter 2012 Table of Contents

  •   Email
  •   Print
  •   Share
  • Evolution and Cancer

    • Franziska Michor, PhD.Evolutionary theory can shed light on many issues, including the thorny problem of cancer drug resistance, believes Franziska Michor, PhD.
      Read more